Your browser doesn't support javascript.
loading
International expansion of a novel SARS-CoV-2 mutant
Minjin Wang; Mengjiao Li; Ruotong Ren; Andreas Brave; Sylvie van der Werf; En-Qiang Chen; Zhiyong Zong; Weimin Li; Binwu Ying.
Afiliação
  • Minjin Wang; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China
  • Mengjiao Li; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China
  • Ruotong Ren; 1. Genskey Biotechnology Co., Ltd. 2. Department of Hematology, The First Hospital of Lanzhou University
  • Andreas Brave; Department of microbiology,Public Health Agency of Sweden
  • Sylvie van der Werf; Department of Virology,Molecular Genetics of RNA Viruses unit,CNRS UMR-3569, University of Paris, National Reference Center for Respiratory Viruses Institut Pas
  • En-Qiang Chen; Center of Infectious Diseases, West China Hospital of Sichuan University
  • Zhiyong Zong; Department of Infection Control and Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China
  • Weimin Li; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China
  • Binwu Ying; Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20035204
ABSTRACT
Letter to the editor. There is no abstract. The summary was showed SARS-CoV-2 has inevitably mutated during its pandemic spread to cause unpredictable effects on COVID-19 and complicate epidemic control efforts. Here we report that a novel SARS-CoV-2 mutation (ORF3a) appears to be spreading worldwide, which deserves close attention.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...